메뉴 건너뛰기




Volumn 100, Issue 2, 2001, Pages 191-197

Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia

Author keywords

Antibody; huGMCSF diphtheria toxin fusion protein; Myeloid leukemia

Indexed keywords

DIPHTHERIA TOXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

EID: 0034895032     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5066     Document Type: Article
Times cited : (48)

References (14)
  • 2
    • 0030665228 scopus 로고    scopus 로고
    • Long-term survival after chemotherapy for acute myeloid leukemia: The experience of the southwest oncology group
    • (1997) Cancer , vol.80 , pp. 2199-2204
    • Appelbaum, F.R.1    Kopecky, K.J.2
  • 5
    • 0032588869 scopus 로고    scopus 로고
    • 388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte - Macrophage colony-stimulating factor, prolongs survival in a SCID mouse model of acute myeloid leukemia
    • (1999) Leukemia , vol.13 , pp. 629-633
    • Hall, P.D.1    Willingham, M.C.2    Kreitman, R.J.3    Frankel, A.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.